Open AccessThe other possible mechanism of the benefits of RAAS inhibition in the athogenesis of COVID ‐19
Author(s) -
Gupta Neelesh,
Patel Krunalkumar,
Gupta Rajeev
Publication year - 2020
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.23494
Subject(s) - medicine , bradykinin , angiotensin ii , inflammation , renin–angiotensin system , angiotensin converting enzyme 2 , myocardial infarction , tumor necrosis factor alpha , angiotensin converting enzyme , downregulation and upregulation , endocrinology , receptor , ace inhibitor , pharmacology , blood pressure , disease , covid-19 , infectious disease (medical specialty) , biology , biochemistry , gene